Shortening the window between doses leads to medication accumulation, which can cause severe, avoidable side effects without significantly improving weight loss outcomes
Funding This study was done with internal departmental funding from the Department of Anesthesia and Pain Management, Toronto Western Hospital, University Health Network (Toronto, ON, Canada)
High adiponectin levels in PWS may contribute to a good glucose and fat metabolic microenvironment, whereas low adiponectin levels in general obesity may be a reflection of microenvironmental dysfunction and an unhealthy AT expansion [63]
Ridker PM, Macfadyen JG, Glynn RJ et al (2018) Inhibition of interleukin-1 by canakinumab and cardiovascular outcomes in patients with chronic kidney disease
Ipamorelin is not an FDA-approved drug